BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

19 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Acroamine A, a 2-Amino Adenine Alkaloid from the Marine Soft Coral Acrozoanthus australiae and Its Semisynthetic Derivatives That Inhibit cAMP-Dependent Protein Kinase A Catalytic Subunit Alpha.EBI
National Cancer Institute
Discovery and Synthesis of a Naturally Derived Protein Kinase Inhibitor that Selectively Inhibits Distinct Classes of Serine/Threonine Kinases.EBI
National Cancer Institute
Neopetrotaurines A-C, Isoquinoline Alkaloids with an Unprecedented Taurine Bridge from the Sponge EBI
National Cancer Institute
Covalent Small Molecule Immunomodulators Targeting the Protease Active Site.EBI
National Cancer Institute
Biological Effects of Modifications of the Englerin A Glycolate.EBI
National Cancer Institute
Identification of a New Heterocyclic Scaffold for Inhibitors of the Polo-Box Domain of Polo-like Kinase 1.EBI
National Cancer Institute
Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide.EBI
National Cancer Institute
Secondary Metabolites from the Fungus Dictyosporium sp. and Their MALT1 Inhibitory Activities.EBI
National Cancer Institute
Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300.EBI
National Cancer Institute
Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.EBI
National Cancer Institute
Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: new lead exhibits a distinct binding mode.EBI
National Cancer Institute
Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties.EBI
National Cancer Institute
Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.EBI
National Cancer Institute
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program.EBI
National Cancer Institute
A reinvestigation of Maprounea triterpenes.EBI
National Cancer Institute
A novel phorbol ester from Excoecaria agallocha.EBI
National Cancer Institute
HIV inhibitory natural products. 26. Quinoline alkaloids from Euodia roxburghiana.EBI
National Cancer Institute
Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA.EBI
National Cancer Institute
Macrophilones from the Marine Hydroid Macrorhynchia philippina Can Inhibit ERK Cascade Signaling.EBI
National Cancer Institute